Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidative stress signaling mediators represent a broad class of molecules, including reactive oxygen species (ROS), antioxidant enzymes, and redox-sensitive transcription factors, that collectively maintain cellular redox homeostasis. Key components such as the Nrf2-Keap1 pathway and NF-kappaB serve as sensors that detect oxidative imbalances and initiate gene expression programs to mitigate damage (Sies & Jones, 2020, Nature Reviews Molecular Cell Biology). In pathological states like cancer, neurodegeneration, and cardiovascular disease, these mediators often become dysregulated, leading to chronic oxidative stress and tissue injury (Forman & Zhang, 2021, Nature Reviews Drug Discovery). Pharmacological strategies targeting these mediators include the use of direct antioxidants to scavenge ROS or Nrf2 activators to bolster endogenous defense mechanisms (Hayes & Dinkova-Kostova, 2014, Trends in Biochemical Sciences). However, the dual role of ROS as both damaging agents and essential signaling molecules for cell growth and immunity creates a therapeutic challenge known as the antioxidant paradox (Halliwell, 2011, Free Radical Research). Consequently, drug development in this area requires precise modulation to avoid disrupting necessary physiological signaling while effectively reducing pathological oxidative stress.
Activation of antioxidant response elements (ARE) via Nrf2, inhibition of NF-kappaB signaling, and direct scavenging of reactive oxygen species.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidative stress signaling mediators.